The local medical landscape is excited with the introduction of retatrutide, a novel dual GIP and GLP-1 receptor showing impressive results in clinical trials for treating obesity. This therapy promises https://altbookmark.com/story23735255/retatrutide-australia-a-emerging-hope-for-weight-management